Literature DB >> 27080982

HLA-G 14-bp polymorphism affects the age of onset in Type I Diabetes Mellitus.

P Gerasimou1,2, N Skordis3, M Picolos4, A Spyridonidis5, P Costeas1.   

Abstract

Type I diabetes mellitus (T1DM) is an organ-specific autoimmune disorder affecting the insulin-producing pancreatic cells. T1DM genetic association studies have so far revealed the involvement of more than 40 loci, with particularly strong associations for the human leucocyte antigens (HLA). Further to the well-established HLA class II associations, the immunomodulatory elements in the telomeric major histocompatibility complex locus, specifically nonclassical HLA class I, were also associated with T1DM, either in conferring susceptibility or by contributing to the overall pathogenesis. This study investigates the involvement of a 14-bp deletion polymorphism (rs371194629) at the 3' untranslated region of HLA-G in the context of T1DM and age of onset. The frequency of the polymorphism was determined in unrelated T1DM Cypriot patients and findings that emerge from this study show a strong association between the HLA-G 14-bp polymorphism and T1DM with respect to the age of onset. Specifically, the deletion/deletion (DEL/DEL) genotype was found to be associated with an early age of onset (P = 0.001), while the presence of the insertion allele (INS) was associated to a later age of onset (P = 0.0001), portraying a possible dominant effect over the deletion allele, a role in delaying disease onset and an overall involvement of HLA-G in the pathogenesis of type I diabetes mellitus.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27080982     DOI: 10.1111/iji.12259

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN: 1744-3121            Impact factor:   1.466


  6 in total

1.  Combined effect of glutamine at position 70 of HLA-DRB1 and alanine at position 57 of HLA-DQB1 in type 1 diabetes: An epitope analysis.

Authors:  Petroula Gerasimou; Vicky Nicolaidou; Nicos Skordis; Michalis Picolos; Demetrios Monos; Paul A Costeas
Journal:  PLoS One       Date:  2018-03-01       Impact factor: 3.240

2.  Altered Frequency and Phenotype of HLA-G-Expressing DC-10 in Type 1 Diabetes Patients at Onset and in Subjects at Risk to Develop the Disease.

Authors:  Giada Amodio; Alessandra Mandelli; Rosalia Curto; Paola M V Rancoita; Angela Stabilini; Riccardo Bonfanti; Maurizio de Pellegrin; Emanuele Bosi; Clelia Di Serio; Manuela Battaglia; Silvia Gregori
Journal:  Front Immunol       Date:  2021-10-01       Impact factor: 7.561

Review 3.  Single-nucleotide polymorphisms as important risk factors of diabetes among Middle East population.

Authors:  Iman Akhlaghipour; Amir Reza Bina; Mohammad Reza Mogharrabi; Ali Fanoodi; Amir Reza Ebrahimian; Soroush Khojasteh Kaffash; Atefeh Babazadeh Baghan; Mohammad Erfan Khorashadizadeh; Negin Taghehchian; Meysam Moghbeli
Journal:  Hum Genomics       Date:  2022-04-02       Impact factor: 4.639

Review 4.  HLA-G Genotype/Expression/Disease Association Studies: Success, Hurdles, and Perspectives.

Authors:  Giada Amodio; Silvia Gregori
Journal:  Front Immunol       Date:  2020-07-08       Impact factor: 7.561

Review 5.  What the HLA-I!-Classical and Non-classical HLA Class I and Their Potential Roles in Type 1 Diabetes.

Authors:  Rebecca C Wyatt; Giacomo Lanzoni; Mark A Russell; Ivan Gerling; Sarah J Richardson
Journal:  Curr Diab Rep       Date:  2019-12-09       Impact factor: 4.810

Review 6.  The HLA-G Immune Checkpoint Plays a Pivotal Role in the Regulation of Immune Response in Autoimmune Diseases.

Authors:  Monika Zaborek-Łyczba; Jakub Łyczba; Paulina Mertowska; Sebastian Mertowski; Anna Hymos; Martyna Podgajna; Paulina Niedźwiedzka-Rystwej; Ewelina Grywalska
Journal:  Int J Mol Sci       Date:  2021-12-12       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.